Analyst firms · Wolfe Research · VRNS

Wolfe Research VRNS price target and rating history

Varonis Systems Inc. (VRNS) · Technology

Wolfe Research rates Varonis Systems Inc. (VRNS) Outperform with a $50 price target, as of its latest action on Mar 28, 2025. It has published 3 rating actions on VRNS since August 2021, including 1 upgrade and 1 downgrade. Across 8 firms with a VRNS price target in the last 12 months, the median target is $45.50.

Current rating
Outperform
Price target
$50
Median target, all firms
$45.50
Actions on VRNS
3

Wolfe Research price target on VRNS

$80$65$5020222023202420252026
Wolfe Research price target on VRNS, each point a stated target, August 2021 to March 2025.

Every Wolfe Research rating on VRNS

How other firms rate VRNS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
SusquehannaNeutral$49.75Nov 5, 2026
StephensEqual-Weight$45Oct 27, 2026
BarclaysEqual Weight$50Oct 19, 2026
WedbushNeutral$46Sep 11, 2026
KeyBanc Capital MarketsSector WeightMay 26, 2026
William BlairMkt PerformMar 23, 2026
Wells FargoOverweight$28Mar 3, 2026
DA DavidsonBuy$30Feb 5, 2026
Morgan StanleyEqual-Weight$41Jan 26, 2026
Piper SandlerOverweight$47Jan 5, 2026

Questions about Wolfe Research and VRNS

What is Wolfe Research's price target for VRNS?
Wolfe Research's latest stated price target for Varonis Systems Inc. (VRNS) is $50, from its action on Mar 28, 2025.
What is Wolfe Research's rating on VRNS?
Wolfe Research rates VRNS Outperform, a bullish rating, as of Mar 28, 2025.
When did Wolfe Research last change its view on VRNS?
On Mar 28, 2025, Wolfe Research upgrades to Outperform from Peer Perform, price target $50.
How does Wolfe Research's VRNS target compare with other analysts?
Across 8 firms with a VRNS price target in the last 12 months, the median target is $45.50.

More VRNS rating histories

All Wolfe Research ratingsVRNS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.